化学
神经保护
神经突
组蛋白脱乙酰基酶
脚手架
药物发现
药理学
组蛋白脱乙酰酶抑制剂
体外
生物化学
组蛋白
生物
医学
基因
生物医学工程
作者
Wen Wen,Jiadong Hu,Chenxi Wang,Rui Yang,Yabo Zhang,Bingqing Huang,Tingting Qiao,Jiayun Wang,Xin Chen
标识
DOI:10.1016/j.bmcl.2024.129670
摘要
Histone deacetylase 6 (HDAC6) has drawn more and more attention for its potential application in Alzheimer's disease (AD) therapy. A series of tetrahydro-β-carboline (THβC) hydroxamic acids with aryl linker were synthesized. In enzymatic assay, all compounds exhibited nanomolar IC50 values. The most promising compound 11d preferentially inhibited HDAC6 (IC50, 8.64 nM) with approximately 149-fold selectivity over HDAC1. Molecular simulation revealed that the hydroxamic acid of 11d could bind to the zinc ion by a bidentate chelating manner. In vitro, 11d induced neurite outgrowth of PC12 cells without producing toxic effects and showed obvious neuroprotective activity in a model of H2O2-induced oxidative stress.
科研通智能强力驱动
Strongly Powered by AbleSci AI